We're on a mission to help people by renewing their skin.
Our name translates to "new layers," which perfectly describes our belief that visible results come from renewing layers of the skin.
The NEOSTRATA® difference.
OUR PRODUCTS EXFOLIATE THE SURFACE OF YOUR SKIN, REVEALING FRESH, NEW LAYERS.
WE DEVELOP OUR PRODUCTS AT THE PH LEVEL THAT YOUR SKIN ABSORBS MOST EFFECTIVELY.
WE TARGET THE BUILDING BLOCKS OF SKIN'S MATRIX FOR LONG-TERM RESULTS.
We have been researching topical skincare ingredients for over 40 years, discovering and patenting some of the best-known technologies, like Glycolic Acid, which have been licensed within the skincare industry worldwide.
In 1974 our founders discovered the profound benefits of Alpha Hydroxy Acids (AHAs) on skin, setting in motion a reputation for discovery and innovation in skincare that continues today.
ALPHA HYDROXY ACIDS
A breakthrough discovery by our founders, Alpha Hydroxy Acids are a family of naturally occurring acids that have the unique ability to slough away surface skin cells to reveal new healthy ones for softer, smoother, less visibly lined skin.
2nd generation hydroxy acids. Polyhydroxy Acids (PHAs) are similar to AHAs but provide high-strength antiaging benefits without irritation – an ideal choice for sensitive skin types.
BIONIC POLYHYDROXY ACIDS
3rd generation hydroxy acids. Bionic Polyhydroxy Acids are non-irritating, but they are also strong chelators and humectants – ideal for very dehydrated, dry skin types.
Only available from NEOSTRATA®, this non-acid amino sugar technology is a building block of skin’s natural filler hyaluronic acid and is an advanced molecule that gently exfoliates to reveal fresh new cells, diminishes the appearance of lines and wrinkles, and targets hyperpigmented spots and acne for a more even skin tone.
Another NEOSTRATA® innovation, this revolutionary technology helps to reinforce the skin’s matrix to volumize, plump and firm skin for a more lifted appearance.
Is sold by doctors in 85 countries and has more than 100 publications and patents.